During the past decade, Klinikum Frankfurt (Oder) GmbH conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Frankfurt (Oder) GmbH" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials, followed by "German CLL Study Group" with 4 trials sponsored, "Charite University, Berlin, Germany" with 3 trials sponsored, "Biotronik SE & Co. KG" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Frankfurt (Oder) GmbH" #1 collaborator was "Amgen" with 2 trials as a collaborator, "BARMER" with 2 trials as a collaborator, "German CLL Study Group" with 2 trials as a collaborator, "Technische Universität Berlin" with 2 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Frankfurt (Oder) GmbH" are "Lymphoma" (5 trials), "Chronic Lymphocytic Leukemia" (4 trials), "Multiple Myeloma" (2 trials), "AML" (1 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Klinikum Frankfurt (Oder) GmbH" in a lesser frequency.

Most popular intervention types in "Klinikum Frankfurt (Oder) GmbH" are "Drug" (22 trials), "Biological" (9 trials), "Radiation" (5 trials), "Behavioral" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "doxorubicin hydrochloride" (5 trials), "prednisone" (5 trials), "vincristine sulfate" (5 trials) and "Rituximab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Frankfurt (Oder) GmbH" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Frankfurt (Oder) GmbH". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Klinikum Frankfurt (Oder) GmbH, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Frankfurt (Oder) GmbH, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".